Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions

SD Finley, AS Popel - JNCI: Journal of the National Cancer …, 2013 - academic.oup.com
Background Vascular endothelial growth factor (VEGF) is known to be a potent promoter of
angiogenesis under both physiological and pathological conditions. Given its role in …

Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells

F Mac Gabhann, AS Popel - American Journal of …, 2004 - journals.physiology.org
Placental growth factor (PlGF) competes with vascular endothelial growth factor (VEGF) for
binding to VEGF receptor (VEGFR)-1 but does not bind VEGFR2. Experiments show that …

Mathematical modeling of cellular cross-talk between endothelial and tumor cells highlights counterintuitive effects of VEGF-targeted therapies

H Jain, T Jackson - Bulletin of mathematical biology, 2018 - Springer
Tumor growth and progression are critically dependent on the establishment of a vascular
support system. This is often accomplished via the expression of pro-angiogenic growth …

[HTML][HTML] Computational modeling of interacting VEGF and soluble VEGF receptor concentration gradients

YL Hashambhoy, JC Chappell, SM Peirce… - Frontiers in …, 2011 - frontiersin.org
Experimental data indicates that soluble vascular endothelial growth factor (VEGF) receptor
1 (sFlt-1) modulates the guidance cues provided to sprouting blood vessels by VEGF-A. To …

Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking

WH Tan, AS Popel, F Mac Gabhann - Cellular signalling, 2013 - Elsevier
Abstract Vascular Endothelial Growth Factor (VEGF) signal transduction is central to
angiogenesis in development and in pathological conditions such as cancer, retinopathy …

Targeting the VEGF signaling pathway in cancer therapy

MJ Waldner, MF Neurath - Expert opinion on therapeutic targets, 2012 - Taylor & Francis
Introduction: Angiogenesis was first proposed as a possible target for the treatment of
human cancer several decades ago. During recent years, the discovery of VEGF as the main …

[HTML][HTML] Elucidating activation and deactivation dynamics of VEGFR-2 transmembrane domain with coarse-grained molecular dynamics simulations

YJ Go, M Kalathingal, YM Rhee - PloS one, 2023 - journals.plos.org
The vascular endothelial growth factor receptor 2 (VEGFR-2) is a member of receptor
tyrosine kinases (RTKs) and is a dimeric membrane protein that functions as a primary …

Mathematical models of the VEGF receptor and its role in cancer therapy

T Alarcón, KM Page - Journal of The Royal Society …, 2007 - royalsocietypublishing.org
We present an analysis of a stochastic model of the vascular endothelial growth factor
(VEGF) receptor. This analysis addresses the contribution of ligand-binding-induced …

[HTML][HTML] Discovery of high-affinity PDGF-VEGFR interactions: redefining RTK dynamics

SB Mamer, S Chen, JC Weddell, A Palasz… - Scientific reports, 2017 - nature.com
Nearly all studies of angiogenesis have focused on uni-family ligand-receptor binding, eg,
VEGFs bind to VEGF receptors, PDGFs bind to PDGF receptors, etc. The discovery of VEGF …

Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors

E Rathi, A Kumar, SG Kini - Journal of Receptors and Signal …, 2019 - Taylor & Francis
Vascular endothelial growth factor-A (VEGF-A) is a crucial member of the Vascular
endothelial growth factor (VEGF) family which mediates the metastasis of tumor by …